Emily Becker

Emily’s career in Regulatory Affairs began at Reglera, which was acquired by Dohmen Life Science Services (DLSS) in 2012. She progressed from Intern to Senior Manager of Regulatory Affairs in five short years. Her rapid-trajectory career path exposed her to regulatory strategy and successful strategy execution for a variety of technologies and therapeutic areas. When DLSS was acquired by EVERSANA in 2017, Emily was made the company’s Regulatory Affairs Director, responsible for management and growth of the Regulatory Affairs Consulting team and the development, leadership, and execution of client regulatory strategy across the highly regulated medical device, pharmaceutical, biologic, combination product, and human tissue industries all over the globe. This responsibility included acting as the client liaison with the US Food and Drug Administration and similar International regulatory agencies. She was responsible for advising on GDPR compliance for clients performing clinical trials in the EU and also assumed the responsibilities of HIPAA Privacy Officer for both EVERSANA and client companies.

​

Emily is responsible for implementing and maintaining OnemataDC’s global Regulatory Affairs program and is also responsible for OnemataDC’s Government Affairs, liaising with state and federal legislative bodies and government agencies to represent the company’s viewpoints and actively participate as a stakeholder. Emily has a passion for living in the grey of regulations to creatively and innovatively achieve compliance with unwavering integrity in support of OnemataDC and our clients' efforts.